Blog

Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24

Photo taken from Oncology Brothers/X

May 28, 2024, 07:58

Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24

Rahul Gosain, Director of Regional Infusion Services at

“GI Series: As you get ready for ASCO 24, Rohit Gosain, MD and I recap ASCO 23 plenary discussion, importance of MultiD approach, and the current landscape of Rectal Cancer with Deb Schrag & Krishan Jethwa

Selective omission of Surgery, XRT, and Chemo is the key.

Full discussion:

Also on the “Oncology Brothers” podcast.”

Source: Rahul Gosain/LinkedIn
.

ASCO 23 ASCO 24 cancer current landscape of rectal cancer Deb Schrag GI Series Krishan Jethwa MultiD approach OncoDaily Oncology Oncology Brothers podcast plenary discussion Rahul Gosain rectal cancer rectal cancer treatment Rohit Gosain MD selective omission of chemo selective omission of surgery selective omission of XRT Wilmot Cancer Institute

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage